HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The Prognostic Impact of the Aryl Hydrocarbon Receptor (AhR) in Primary Breast Cancer Depends on the Lymph Node Status.

Abstract
Increasing evidence implicates the aryl hydrocarbon receptor (AhR) as a possible regulator of mammary carcinogenesis. This study aims to clarify its prognostic impact in breast cancer (BC). Meta-analyses performed at the mRNA level demonstrated that the predictive value of AhR expression in BC depends on the lymph node (LN) status. AhR expression and sub-cellular location were then analyzed by immunohistochemistry in 302 primary BC samples. AhR was expressed in almost 90% of cases with a predominant nuclear location. Nuclear and cytoplasmic AhR levels were significantly correlated and associated with the expression of RIP140 (receptor-interacting protein of 140 kDa), an AhR transcriptional coregulator and target gene. Interestingly, total and nuclear AhR levels were only significantly correlated with short overall survival in node-negative patients. In this sub-group, total and nuclear AhR expression had an even stronger prognostic impact in patients with low RIP140-expressing tumors. Very interestingly, the total AhR prognostic value was also significant in luminal-like BCs and was an independent prognostic marker for LN-negative patients. Altogether, this study suggests that AhR is a marker of poor prognosis for patients with LN-negative luminal-like BCs, which warrants further evaluation.
AuthorsUdo Jeschke, Xi Zhang, Christina Kuhn, Stéphan Jalaguier, Jacques Colinge, Kristina Pfender, Doris Mayr, Nina Ditsch, Nadia Harbeck, Sven Mahner, Sophie Sixou, Vincent Cavaillès
JournalInternational journal of molecular sciences (Int J Mol Sci) Vol. 20 Issue 5 (Feb 26 2019) ISSN: 1422-0067 [Electronic] Switzerland
PMID30813617 (Publication Type: Journal Article)
Chemical References
  • NRIP1 protein, human
  • Nuclear Receptor Interacting Protein 1
  • RNA, Messenger
  • Receptors, Aryl Hydrocarbon
Topics
  • Breast Neoplasms (genetics, metabolism, pathology)
  • Female
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Lymph Nodes (pathology)
  • Nuclear Receptor Interacting Protein 1 (metabolism)
  • Prognosis
  • RNA, Messenger (genetics, metabolism)
  • Receptors, Aryl Hydrocarbon (genetics, metabolism)
  • Survival Analysis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: